Selenium and Selenoproteins in Immune Mediated Thyroid Disorders
AbstractSelenium is an essential micronutrient that is required for the synthesis of selenocysteine-containing selenoproteins, processing a wide range of health effects. It is known that the thyroid is one of the tissues that contain more selenium. The “selenostasis” maintenance seems to contribute to the prevention of immune mediated thyroid disorders. Prospective, observational studies, randomized, controlled studies evaluating selenium supplementation, and review articles that are available in Medline and PubMed have undergone scrutiny. The differences concerning methodology and results variability have been analyzed. Several authors support the idea of a potential efficacy of selenium (mainly selenomethionine) supplementation in reducing antithyroperoxidase antibody levels and improve thyroid ultrasound features. In mild Graves’ orbitopathy, selenium supplementation has been associated with a decrease of the activity, as well as with quality of life improvement. Future research is necessary to clearly understand the selenium supplementation biologic effects while considering the basal selenium levels/biomarkers, selenoprotein gene polymorphisms that may be involved, underlying comorbidities and the major clinical outcomes. View Full-Text
Share & Cite This Article
Santos, L.R.; Neves, C.; Melo, M.; Soares, P. Selenium and Selenoproteins in Immune Mediated Thyroid Disorders. Diagnostics 2018, 8, 70.
Santos LR, Neves C, Melo M, Soares P. Selenium and Selenoproteins in Immune Mediated Thyroid Disorders. Diagnostics. 2018; 8(4):70.Chicago/Turabian Style
Santos, Liliana R.; Neves, Celestino; Melo, Miguel; Soares, Paula. 2018. "Selenium and Selenoproteins in Immune Mediated Thyroid Disorders." Diagnostics 8, no. 4: 70.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.